Navigation Links
Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
Date:10/21/2009

INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ --

  • Higher volume drives revenue growth
  • Stronger dollar results in improved gross margin
  • Earnings per share increase to $.86 (reported) or $1.20 (pro forma non-GAAP)
  • Full-year 2009 EPS guidance range revised to $3.90 - $4.00 (reported) or $4.30 - $4.40 (pro forma non-GAAP)

Eli Lilly and Company (NYSE: LLY) today announced financial results for the third quarter of 2009.


    $in millions, except per share data          Third Quarter
                                                 -------------
                                                2009      2008  % Growth
                                                ----      ----  --------
    Total Revenue - Reported                $5,562.0  $5,209.5       7%
    Net Income (loss) - Reported               941.8    (465.6)     NM
    (Loss per share) - Reported                  .86      (.43)     NM

    Total Revenue - Pro forma                5,562.0   5,308.7       5%
    Net Income - Pro forma non-GAAP          1,311.8   1,075.4      22%
    EPS - Pro forma non-GAAP                    1.20       .98      22%
    ========================                    ====       ===      ==

    NM - not meaningful

Due to significant strategic actions taken by the company, financial results for 2009 and 2008 are presented on both a reported and a pro forma non-GAAP basis. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all revenue and expenses recognized during the period. Pro forma non-GAAP results exclude significant items described in the reconciliation tables and also assume the ImClone acquisition was completed January 1, 2008. The pro forma non-GAAP results are presented in order to provide
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Lilly Declares Fourth-Quarter Dividend
2. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
3. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
4. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
5. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
6. Study Showed Lillys GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
7. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
8. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
9. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
10. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
11. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
(Date:12/22/2014)... LUXEMBOURG , Dec. 22, 2014  ConvaTec, a ... Paul Moraviec has been appointed Interim Chief Executive Officer ... Mr. Moraviec succeeds Ken Berger .  "The Board ... service in leading ConvaTec over the past three years," ... Board of Directors.  "We are confident that the company ...
(Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals Incorporated ... study of lonafarnib in patients with chronic hepatitis ... at the National Institutes of Health (NIH) Clinical ...  The double-blinded, randomized, placebo-controlled, dose ascending study evaluated ... and 200 mg twice daily for 28 days.  ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... Adeona Pharmaceuticals, Inc. (NYSE Amex: ... serious central nervous system diseases, announced that the Company,s ... a new Phase II clinical trial to evaluate its ... multiple sclerosis (MS) patients. The Skirball Foundation and Adeona ...
... Connecticut, November 11, 2011 At RSNA ... Sectra   (NASDAQ OMX Stockholm: SECT B), ... tomosynthesis images in Sectra Breast Imaging PACS. ... PACS do not support images of this type, a dedicated ...
Cached Medicine Technology:Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 2Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 3Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 4Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research 5Sectra Launches Support for Breast Tomosynthesis Images in PACS 2
(Date:12/22/2014)... As part of a company-wide ... in San Diego and surrounding areas, Golden ... care team with ongoing online training courses. , ... provided by Caregiverlist®. Caregiverlist® is “the premiere ... most reliable eldercare options, highest quality ratings and ...
(Date:12/22/2014)... LENEXA, Kan. (PRWEB) December 22, 2014 ... it will add a subscription option to their ad ... for report writing services. Customers can sign up for ... report writing hours each month at a deeply discounted ... pricing tiers, and each has a progressively discounted rate. ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 ... current Ebola virus epidemic are receiving further ... government agencies, nongovernmental organizations (NGOs) and other ... ongoing, healthcare workers, emergency responders, patients and ... such as the CmTP MediDefense system ...
(Date:12/22/2014)... NY (PRWEB) December 22, 2014 ... stronger than ever, having invested more than $5 ... service members, veterans and their families. , This ... nearly a dozen nonprofits, helping with: veteran entrepreneurship; ... scholarships; and life-coaches for severely injured veterans. , ...
(Date:12/22/2014)... 2014 Give a loved one the ... of health and vitality. , For a limited time, ... anti-aging formulas in special Holiday Wellness gift packages at ... , Each bottle contains cutting-edge, proven nutritional support for ... as well as we age. , Joint ...
Breaking Medicine News(10 mins):Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2
... , WEDNESDAY, Dec. 7 (HealthDay News) -- Hispanic women ... breast cancer than non-Hispanic white women, according to a ... could explain this discrepancy, the researchers suggested. "This ... is less responsive to chemotherapy," Kathy Baumgartner, an epidemiology ...
... mastectomy (CPM), a procedure that removes the unaffected breast ... a modest increase in life expectancy, according to a ... Medicine at the University of Pennsylvania. In fact, the ... quality-adjusted life expectancy a measure of life expectancy ...
... or adults, often takes place even in the absence ... Current methods to treat such overeating in youth focus ... them to track their food intake and engage in ... therapy techniques don,t work long term, according to Kerri ...
... HealthDay Reporter , WEDNESDAY, Dec. 7 (HealthDay News) ... with low-risk prostate cancer, a new draft report released ... concluded that research on the safety of "active surveillance" ... men opt for surgery or other treatments that can ...
... Autism Speaks Chief Science Officer Geri Dawson, Ph.D. and Assistant VP, ... Speaks "Office Hour: The Doctors Are In," a monthly live web ... each month from 3:00 - 4:00 pm Eastern / 12:00 noon ... At the time of the web chat, viewers simply log in ...
... to prevent HIV infection. Called pre-exposure prophylaxis, or PrEP, it is ... exposed to the virus. Having shown great promise in recent phase ... use. Because PrEP is based on the same ... is that the dual use of these drugs will lead to ...
Cached Medicine News:Health News:Hispanic Women More Likely to Die of Breast Cancer 2Health News:Contralateral prophylactic mastectomy offers limited gains for breast cancer patients 2Health News:Contralateral prophylactic mastectomy offers limited gains for breast cancer patients 3Health News:New approach to management of overeating in children 2Health News:New approach to management of overeating in children 3Health News:Active Surveillance May Benefit Men With Low-Risk Prostate Cancer 2Health News:New Autism Speaks 'Office Hour: The Doctors Are In' monthly live web chat 2Health News:UCLA researchers suggest unconventional approach to control HIV epidemics 2Health News:UCLA researchers suggest unconventional approach to control HIV epidemics 3
Full plate covers seal all 24 MicroAmp tubes...
96-Well PCR Plate Sealing Mat...
Easy to pierce, remove using foil stripper...
Inquire...
Medicine Products: